Big tobacco’s PMI makes another pharma foray with Vectura deal
pharmaphorum
JULY 9, 2021
Tobacco giant Philip Morris International (PMI) has doubled down on its move into the pharmaceutical sector, following up its recent acquisition of Fertin Pharma with a deal to buy Vectura for around £1 billion ($1.38 The UK pharma company says it has now withdrawn its recommendation to shareholders to accept that deal.
Let's personalize your content